Exhibit 107

Calculation of Filing Fee Table

FORM S-3

(Form Type)

Atara Biotherapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

Security
Class

Title

  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

  Amount of
Registration
Fee
 

Carry
Forward

Form
Type

 

Carry

Forward

File

Number

  Carry
Forward
Initial
effective
date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity   Common Stock, par value $0.0001 per share     (1)(2)   (1)   (3)            
                         
Fees to Be Paid   Equity   Preferred Stock, par value $0.0001 per share     (1)(2)   (1)   (3)            
                         
Fees to Be Paid   Debt   Debt Securities     (1)   (1)   (3)            
                         
Fees to Be Paid   Other   Warrants     (1)   (1)   (3)            
                         
Fees to Be Paid   Other   Rights to purchase common stock, preferred stock, debt securities or units     (1)   (1)   (3)            
                         
Fees to Be Paid   Other   Units     (1)   (1)   (3)            
                         
Fees to Be Paid   Unallocated (Universal) Shelf     Rule 457(o)   (1)(2)   (1)   $400,000,000(3)   .00014760   $59,040(4)          
                         
Fees Previously Paid                        
 
Carry Forward Securities
                         

Carry

Forward

Securities

                       
                   
    Total Offering Amounts      $400,000,000   .00014760   $59,040          
                   
    Total Fees Previously Paid                   
                   
    Total Fee Offsets                   
                   
    Net Fee Due                $59,040                

 

(1)

An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities.

(2)

Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $400,000,000.

(4)

The registration fee has been calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended.